UBS AG reiterated their buy rating on shares of Aetna (NYSE:AET) in a research note released on Wednesday morning, American Banking News reports. They currently have a $86.00 target price on the stock, up from their previous target price of $82.00.
Shares of Aetna (NYSE:AET) traded down 0.67% on Wednesday, hitting $72.86. The stock had a trading volume of 987,726 shares. Aetna has a 1-year low of $49.68 and a 1-year high of $74.50. The stock’s 50-day moving average is $69.90 and its 200-day moving average is $66.82. The company has a market cap of $26.426 billion and a price-to-earnings ratio of 13.76.
Aetna (NYSE:AET) last announced its earnings results on Thursday, February 6th. The company reported $1.34 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.36 by $0.02. The company had revenue of $13.13 billion for the quarter, compared to the consensus estimate of $13.14 billion. During the same quarter in the prior year, the company posted $0.94 earnings per share. The company’s quarterly revenue was up 46.7% on a year-over-year basis. On average, analysts predict that Aetna will post $6.38 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, April 25th. Shareholders of record on Thursday, April 10th will be given a dividend of $0.225 per share. This represents a $0.90 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Tuesday, April 8th.
A number of other analysts have also recently weighed in on AET. Analysts at Jefferies Group raised their price target on shares of Aetna to $87.00 in a research note on Friday, March 7th. They now have a buy rating on the stock. Separately, analysts at EVA Dimensions upgraded shares of Aetna from an underweight rating to a hold rating in a research note on Tuesday, March 4th. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Aetna to $75.00 in a research note on Monday, February 10th. Four research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $75.25.
Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.
To view UBS AG’s full report, visit UBS AG’s official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.